Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 56,785	$ 77,258
Accounts receivable	31	200
Prepaid expenses, deposits, and other current assets	5,163	5,179
Total current assets	61,979	82,637
Fixed assets, net	2,374	1,585
Operating lease right-of-use assets	3,079
Intangible assets, net	3,950	2,029
Other assets	1,083	725
Total assets	72,465	86,976
Current liabilities:
Accounts payable	2,454	3,299
Accrued expenses and other current liabilities	2,930	4,259
Operating lease liabilities, current portion	1,027
Senior Secured Convertible Notes - at fair value	35,500
Total current liabilities	41,911	7,558
Operating lease liabilities, less current portion	1,998
Total liabilities	43,909	7,558
Commitments and contingencies (Note 9)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,182,101 at September 30, 2022 and 1,113,919 shares at December 31, 2021	2,624	2,419
Common stock, $0.001 par value. Authorized, 250,000,000 shares; 92,228,862 and 86,367,845 shares outstanding as of September 30, 2022 and December 31, 2021, respectively	92	86
Additional paid-in capital	214,278	198,071
Accumulated deficit	(207,638)	(138,910)
Treasury stock	(408)
Total PAVmed Inc. Stockholders’ Equity	8,948	61,666
Noncontrolling interests	19,608	17,752
Total Stockholders’ Equity	28,556	79,418
Total Liabilities and Stockholders’ Equity	$ 72,465	$ 86,976